ID   RXF 393L
AC   CVCL_1673
SY   RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL
DR   BTO; BTO_0004207
DR   CLO; CLO_0009982
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1673
DR   Cell_Model_Passport; SIDM00086
DR   ChEMBL-Cells; CHEMBL3307734
DR   ChEMBL-Targets; CHEMBL614886
DR   Cosmic; 875872
DR   Cosmic; 905978
DR   Cosmic; 974306
DR   Cosmic; 1175851
DR   Cosmic; 1305376
DR   Cosmic; 1312364
DR   Cosmic; 1998471
DR   Cosmic-CLP; 905978
DR   DepMap; ACH-002195
DR   EGA; EGAS00001000978
DR   GDSC; 905978
DR   GEO; GSM2100
DR   GEO; GSM743484
DR   GEO; GSM750839
DR   GEO; GSM799375
DR   GEO; GSM799438
DR   GEO; GSM844678
DR   GEO; GSM844679
DR   GEO; GSM847111
DR   GEO; GSM1153448
DR   GEO; GSM1178577
DR   GEO; GSM1178578
DR   GEO; GSM1178579
DR   GEO; GSM1181369
DR   GEO; GSM1181370
DR   GEO; GSM1670398
DR   GEO; GSM2124681
DR   IARC_TP53; 18073
DR   LINCS_LDP; LCL-1770
DR   NCI-DTP; RXF 393
DR   PharmacoDB; RXF393_1338_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1673
DR   PubChem_Cell_line; CVCL_1673
DR   SKY/M-FISH/CGH; 2800
DR   Wikidata; Q54951507
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=39
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/rxf393-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 62.9 hours (NCI-DTP=RXF 393).
CC   HLA typing: A*02,24; B*14:01,44; C*05,08:02; DPB1*01:01:01,04:01; DQB1*03:01:01,06:02; DRB1*11:01:01,15:01:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; Cosmic-CLP=905978; DepMap=ACH-002195).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.51%; Native American=0.1%; East Asian, North=0%; East Asian, South=0.68%; South Asian=3.61%; European, North=57.95%; European, South=37.15% (PubMed=30894373).
CC   Misspelling: RXF393-RU; Cosmic=1175851.
ST   Source(s): Cosmic-CLP=905978; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 28,33.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24,27
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
RX   PubMed=9331090;
RA   O'Connor, Patrick M.
RA   Jackman, Joany
RA   Bae, Insoo
RA   Myers, Timothy Gene
RA   Fan, Sai-Jun
RA   Mutoh, Masato
RA   Scudiero, Dominic A.
RA   Monks, Anne
RA   Sausville, Edward A.
RA   Weinstein, John N.
RA   Friend, Stephen H.
RA   Fornace, Albert J. Jr.
RA   Kohn, Kurt W.
RT   "Characterization of the p53 tumor suppressor pathway in cell lines of
RT   the National Cancer Institute anticancer drug screen and correlations
RT   with the growth-inhibitory potency of 123 anticancer agents.";
RL   Cancer Res. 57:4285-4300(1997).
//
RX   PubMed=15748285; DOI=10.1186/1479-5876-3-11; PMCID=PMC555742;
RA   Adams, Sharon
RA   Robbins, Fu-Meei
RA   Chen, Deborah
RA   Wagage, Devika
RA   Holbeck, Susan L.
RA   Morse, Herbert Carpenter 3rd
RA   Stroncek, David
RA   Marincola, Francesco M.
RT   "HLA class I and II genotype of the NCI-60 cell lines.";
RL   J. Transl. Med. 3:11.1-11.8(2005).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=10700174; DOI=10.1038/73432;
RA   Ross, Douglas T.
RA   Scherf, Uwe
RA   Eisen, Michael Bruce
RA   Perou, Charles M.
RA   Rees, Christian
RA   Spellman, Paul T.
RA   Iyer, Vishwanath R.
RA   Jeffrey, Stefanie S.
RA   van de Rijn, Matt
RA   Waltham, Mark C.
RA   Pergamenschikov, Alexander
RA   Lee, Jeffrey C.F.
RA   Lashkari, Deval
RA   Shalon, Dari
RA   Myers, Timothy Gene
RA   Weinstein, John N.
RA   Botstein, David
RA   Brown, Patrick O'Reilly
RT   "Systematic variation in gene expression patterns in human cancer cell
RT   lines.";
RL   Nat. Genet. 24:227-235(2000).
//
RX   PubMed=27807467; DOI=10.1186/s13100-016-0078-4; PMCID=PMC5087121;
RA   Zampella, John G.
RA   Rodic, Nemanja
RA   Yang, Wan Rou
RA   Huang, Cheng Ran Lisa
RA   Welch, Jane
RA   Gnanakkan, Veena P.
RA   Cornish, Toby Charles
RA   Boeke, Jef D.
RA   Burns, Kathleen H.
RT   "A map of mobile DNA insertions in the NCI-60 human cancer cell
RT   panel.";
RL   Mob. DNA 7:20.1-20.11(2016).
//
RX   PubMed=28489074; DOI=10.1038/ncomms15165; PMCID=PMC5436135;
RA   Sinha, Rileen
RA   Winer, Andrew G.
RA   Chevinsky, Michael Stephen
RA   Jakubowski, Christopher
RA   Chen, Ying-Bei
RA   Dong, Yi-Yu
RA   Tickoo, Satish K.
RA   Reuter, Victor E.
RA   Russo, Paul
RA   Coleman, Jonathan A.
RA   Sander, Chris
RA   Hsieh, James J.-D.
RA   Hakimi, Abraham Ari
RT   "Analysis of renal cancer cell lines from two major resources enables
RT   genomics-guided cell line selection.";
RL   Nat. Commun. 8:15165.1-15165.10(2017).
//
RX   PubMed=24670534; DOI=10.1371/journal.pone.0092047; PMCID=PMC3966786;
RA   Varma, Sudhir
RA   Pommier, Yves
RA   Sunshine, Margot
RA   Weinstein, John N.
RA   Reinhold, William C.
RT   "High resolution copy number variation data in the NCI-60 cancer cell
RT   lines from whole genome microarrays accessible through CellMiner.";
RL   PLoS ONE 9:e92047.1-e92047.15(2014).
//
RX   PubMed=2041050; DOI=10.1093/jnci/83.11.757;
RA   Monks, Anne
RA   Scudiero, Dominic A.
RA   Skehan, Philip
RA   Shoemaker, Robert H.
RA   Paull, Kenneth D.
RA   Vistica, David T.
RA   Hose, Curtis D.
RA   Langley, John
RA   Cronise, Paul
RA   Vaigro-Wolff, Anne
RA   Gray-Goodrich, Marcia
RA   Campbell, Hugh
RA   Mayo, Joseph G.
RA   Boyd, Michael R.
RT   "Feasibility of a high-flux anticancer drug screen using a diverse
RT   panel of cultured human tumor cell lines.";
RL   J. Natl. Cancer Inst. 83:757-766(1991).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, Agda Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=17088437; DOI=10.1158/1535-7163.MCT-06-0433; PMCID=PMC2705832;
RA   Ikediobi, Ogechi N.
RA   Davies, Helen R.
RA   Bignell, Graham Robert
RA   Edkins, Sarah
RA   Stevens, Claire
RA   O'Meara, Sarah
RA   Santarius, Thomas
RA   Avis, Tim
RA   Barthorpe, Syd
RA   Brackenbury, Lisa
RA   Buck, Gemma
RA   Butler, Adam P.
RA   Clements, Jody
RA   Cole, Jennifer
RA   Dicks, Ed
RA   Forbes, Simon
RA   Gray, Kristian
RA   Halliday, Kelly
RA   Harrison, Rachel
RA   Hills, Katy
RA   Hinton, Jonathan
RA   Hunter, Chris
RA   Jenkinson, Andy
RA   Jones, David
RA   Kosmidou, Vivian
RA   Lugg, Richard
RA   Menzies, Andrew
RA   Mironenko, Tatiana
RA   Parker, Adrian
RA   Perry, Janet
RA   Raine, Keiran Martin
RA   Richardson, David
RA   Shepherd, Rebecca
RA   Small, Alex
RA   Smith, Raffaella
RA   Solomon, Helen
RA   Stephens, Philip J.
RA   Teague, Jon W.
RA   Tofts, Calli
RA   Varian, Jennifer
RA   Webb, Tony
RA   West, Sofie
RA   Widaa, Sara
RA   Yates, Andy
RA   Reinhold, William C.
RA   Weinstein, John N.
RA   Stratton, Michael Rudolf
RA   Futreal, P. Andrew
RA   Wooster, Richard
RT   "Mutation analysis of 24 known cancer genes in the NCI-60 cell line
RT   set.";
RL   Mol. Cancer Ther. 5:2606-2612(2006).
//
RX   PubMed=27377824; DOI=10.1038/sdata.2016.52; PMCID=PMC4932877;
RA   Mestdagh, Pieter
RA   Lefever, Steve
RA   Volders, Pieter-Jan
RA   Derveaux, Stefaan
RA   Hellemans, Jan
RA   Vandesompele, Jo
RT   "Long non-coding RNA expression profiling in the NCI60 cancer cell
RT   line panel using high-throughput RT-qPCR.";
RL   Sci. Data 3:160052.1-160052.6(2016).
//
RX   PubMed=23933261; DOI=10.1016/j.celrep.2013.07.018;
RA   Moghaddas Gholami, Amin
RA   Hahne, Hannes
RA   Wu, Zhi-Xiang
RA   Auer, Florian Johann
RA   Meng, Chen
RA   Wilhelm, Mathias
RA   Kuster, Bernhard
RT   "Global proteome analysis of the NCI-60 cell line panel.";
RL   Cell Rep. 4:609-620(2013).
//
RX   PubMed=19372543; DOI=10.1158/1535-7163.MCT-08-0921; PMCID=PMC4020356;
RA   Lorenzi, Philip L.
RA   Reinhold, William C.
RA   Varma, Sudhir
RA   Hutchinson, Amy A.
RA   Pommier, Yves
RA   Chanock, Stephen Jacob
RA   Weinstein, John N.
RT   "DNA fingerprinting of the NCI-60 cell line panel.";
RL   Mol. Cancer Ther. 8:713-724(2009).
//
RX   PubMed=22347499; DOI=10.1371/journal.pone.0031628; PMCID=PMC3276511;
RA   Ruan, Xiao-Yang
RA   Kocher, Jean-Pierre A.
RA   Pommier, Yves
RA   Liu, Hong-Fang
RA   Reinhold, William C.
RT   "Mass homozygotes accumulation in the NCI-60 cancer cell lines as
RT   compared to HapMap trios, and relation to fragile site location.";
RL   PLoS ONE 7:e31628.1-e31628.9(2012).
//
RX   PubMed=38861359; DOI=10.1158/0008-5472.CAN-23-3031; PMCID=PMC11292194;
RA   Kunkel, Mark W.
RA   Coussens, Nathan P.
RA   Morris, Joel
RA   Taylor, Ronald C.
RA   Dexheimer, Thomas S.
RA   Jones, Eric M.
RA   Doroshow, James H.
RA   Teicher, Beverly A.
RT   "HTS384 NCI60: the next phase of the NCI60 screen.";
RL   Cancer Res. 84:2403-2416(2024).
//
RX   PubMed=31733513; DOI=10.1016/j.isci.2019.10.059; PMCID=PMC6889472;
RA   Guo, Tian-Nan
RA   Luna, Augustin
RA   Rajapakse, Vinodh N.
RA   Koh, Gene Ching-Chiek
RA   Wu, Zhi-Cheng
RA   Liu, Wei
RA   Sun, Yao-Ting
RA   Gao, Huan-Huan
RA   Menden, Michael Patrick
RA   Xu, Chao
RA   Calzone, Laurence
RA   Martignetti, Loredana
RA   Auwerx, Chiara
RA   Buljan, Marija
RA   Banaei-Esfahani, Amir
RA   Ori, Alessandro
RA   Iskar, Murat
RA   Gillet, Ludovic C.
RA   Bi, Ran
RA   Zhang, Jiang-Nan
RA   Zhang, Huan-Huan
RA   Yu, Chen-Huan
RA   Zhong, Qing
RA   Varma, Sudhir
RA   Schmitt, Uwe
RA   Qiu, Peng
RA   Zhang, Qiu-Shi
RA   Zhu, Yi
RA   Wild, Peter Johannes
RA   Garnett, Mathew J.
RA   Bork, Peer
RA   Beck, Martin
RA   Liu, Ke-Xin
RA   Saez-Rodriguez, Julio
RA   Elloumi, Fathi
RA   Reinhold, William C.
RA   Sander, Chris
RA   Pommier, Yves
RA   Aebersold, Ruedi
RT   "Quantitative proteome landscape of the NCI-60 cancer cell lines.";
RL   iScience 21:664-680(2019).
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=22068913; DOI=10.1073/pnas.1111840108; PMCID=PMC3219108;
RA   Gillet, Jean-Pierre
RA   Calcagno, Anna Maria
RA   Varma, Sudhir
RA   Marino, Miguel
RA   Green, Lisa J.
RA   Vora, Meena I.
RA   Patel, Chirayu
RA   Orina, Josiah N.
RA   Eliseeva, Tatiana A.
RA   Singal, Vineet
RA   Padmanabhan, Raji
RA   Davidson, Ben
RA   Ganapathi, Ram
RA   Sood, Anil K.
RA   Rueda, Bo R.
RA   Ambudkar, Suresh V.
RA   Gottesman, Michael Marc
RT   "Redefining the relevance of established cancer cell lines to the
RT   study of mechanisms of clinical anti-cancer drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:18708-18713(2011).
//
RX   PubMed=24279929; DOI=10.1186/2049-3002-1-20; PMCID=PMC4178206;
RA   Dolfi, Sonia C.
RA   Chan, Leo Li-Ying
RA   Qiu, Jean
RA   Tedeschi, Philip M.
RA   Bertino, Joseph Rocco
RA   Hirshfield, Kim Marie
RA   Oltvai, Zoltan Nagy
RA   Vazquez, Alexei
RT   "The metabolic demands of cancer cells are coupled to their size and
RT   protein synthesis rates.";
RL   Cancer Metab. 1:20.1-20.13(2013).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=22384151; DOI=10.1371/journal.pone.0032096; PMCID=PMC3285665;
RA   Lee, Jun-Seok
RA   Kim, Yun Kyung
RA   Kim, Han Jo
RA   Hajar, Siti
RA   Tan, Yee Ling
RA   Kang, Nam-Young
RA   Ng, Shin Hui
RA   Yoon, Chang No
RA   Chang, Young-Tae
RT   "Identification of cancer cell-line origins using fluorescence
RT   image-based phenomic screening.";
RL   PLoS ONE 7:e32096.1-e32096.8(2012).
//
RX   PubMed=23856246; DOI=10.1158/0008-5472.CAN-12-3342; PMCID=PMC4893961;
RA   Abaan, Ogan Demir
RA   Polley, Eric C.
RA   Davis, Sean R.
RA   Zhu, Yue-Lin J.
RA   Bilke, Sven
RA   Walker, Robert L.
RA   Pineda, Marbin A.
RA   Gindin, Yevgeniy
RA   Jiang, Yuan
RA   Reinhold, William C.
RA   Holbeck, Susan L.
RA   Simon, Richard M.
RA   Doroshow, James H.
RA   Pommier, Yves
RA   Meltzer, Paul S.
RT   "The exomes of the NCI-60 panel: a genomic resource for cancer biology
RT   and systems pharmacology.";
RL   Cancer Res. 73:4372-4382(2013).
//
RX   PubMed=22628656; DOI=10.1126/science.1218595; PMCID=PMC3526189;
RA   Jain, Mohit
RA   Nilsson, Roland
RA   Sharma, Sonia
RA   Madhusudhan, Nikhil
RA   Kitami, Toshimori
RA   Souza, Amanda L.
RA   Kafri, Ran
RA   Kirschner, Marc Wallace
RA   Clish, Clary B.
RA   Mootha, Vamsi Krishna
RT   "Metabolite profiling identifies a key role for glycine in rapid
RT   cancer cell proliferation.";
RL   Science 336:1040-1044(2012).
//
RX   PubMed=18277095; DOI=10.4161/cbt.7.5.5712;
RA   Berglind, Hanna
RA   Pawitan, Yudi
RA   Kato, Shunsuke
RA   Ishioka, Chikashi
RA   Soussi, Thierry
RT   "Analysis of p53 mutation status in human cancer cell lines: a
RT   paradigm for cell line cross-contamination.";
RL   Cancer Biol. Ther. 7:699-708(2008).
//